ID   32Dcl3
AC   CVCL_0119
SY   32D clone 3; 32D clone3; 32D cl-3; 32D-Cl3; 32D.cl3; 32D:cl3; 32D/cl3; 32D CL3; 32D Cl3; 32D cl3; 32Dc3; 32D.3
DR   BTO; BTO:0002883
DR   CLO; CLO_0001297
DR   CLO; CLO_0051042
DR   CLO; CLO_0051043
DR   MCCL; MCC:0000011
DR   ATCC; CRL-11346
DR   BCRC; 60456
DR   BCRJ; 0333
DR   BioGRID_ORCS_Cell_line; 1637
DR   RCB; RCB1377
DR   RCB; RCB1538
DR   TOKU-E; 294
DR   Wikidata; Q54584864
RX   Patent=US5521295;
RX   PubMed=2668305;
RX   PubMed=10877550;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11346.
CC   Characteristics: Widely used for the in vitro study of hematopoietic cell proliferation, differentiation and apoptosis (PubMed=10877550).
CC   Characteristics: IL3 dependent.
CC   Misspelling: 32Dc13; Note=Occasionally.
CC   Misspelling: 32D c13; Note=Occasionally.
CC   Misspelling: 32D:c13; Note=Occasionally.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0118 ! 32D
SX   Male
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 24
RX   Patent=US5521295;
RA   Pacifici R.E., Thomason A.R.;
RT   "Nucleic acids encoding hybrid receptor molecules.";
RL   Patent number US5521295, 28-May-1996.
RX   PubMed=2668305; DOI=10.1083/jcb.109.2.833;
RA   Migliaccio G., Migliaccio A.R., Kreider B.L., Rovera G., Adamson J.W.;
RT   "Selection of lineage-restricted cell lines immortalized at different
RT   stages of hematopoietic differentiation from the murine cell line
RT   32D.";
RL   J. Cell Biol. 109:833-841(1989).
RX   PubMed=10877550; DOI=10.1182/blood.V95.11.3636;
RA   Agliano A.M., Santangelo C., Silvestri I., Gazzaniga P., Giuliani L.,
RA   Naso G., Frati L., Castiglia R.;
RT   "On chromosomal instability: what is the karyotype of your 32D Cl3
RT   cell line.";
RL   Blood 95:3636-3637(2000).